| pubmed-article:16294263 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C0016658 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C2699549 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C0917713 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C0339510 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C0246719 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C1414083 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C1826421 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C0177804 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C0443172 | lld:lifeskim |
| pubmed-article:16294263 | lifeskim:mentions | umls-concept:C1546988 | lld:lifeskim |
| pubmed-article:16294263 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:16294263 | pubmed:dateCreated | 2005-11-18 | lld:pubmed |
| pubmed-article:16294263 | pubmed:abstractText | Whether greater treatment-related changes in BMD result in greater decreases in fracture risk is controversial. We analyzed the relationship between BMD change and nonvertebral fracture risk in postmenopausal osteoporotic women from the risedronate fracture program. Change in BMD did not influence the magnitude of risedronate's effect on nonvertebral fractures; the incidence of nonvertebral fractures was equally low in treated patients whose BMD increased or decreased. | lld:pubmed |
| pubmed-article:16294263 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16294263 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16294263 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16294263 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16294263 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16294263 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16294263 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16294263 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:16294263 | pubmed:issn | 0884-0431 | lld:pubmed |
| pubmed-article:16294263 | pubmed:author | pubmed-author:WattsNelson... | lld:pubmed |
| pubmed-article:16294263 | pubmed:author | pubmed-author:FelsenbergDie... | lld:pubmed |
| pubmed-article:16294263 | pubmed:author | pubmed-author:GeusensPietP | lld:pubmed |
| pubmed-article:16294263 | pubmed:author | pubmed-author:BartonIan PIP | lld:pubmed |
| pubmed-article:16294263 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16294263 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:16294263 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16294263 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16294263 | pubmed:pagination | 2097-104 | lld:pubmed |
| pubmed-article:16294263 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:meshHeading | pubmed-meshheading:16294263... | lld:pubmed |
| pubmed-article:16294263 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16294263 | pubmed:articleTitle | Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD. | lld:pubmed |
| pubmed-article:16294263 | pubmed:affiliation | University of Cincinnati Bone Health and Osteoporosis Center, Ohio, USA. nelson.watts@uc.edu | lld:pubmed |
| pubmed-article:16294263 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16294263 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16294263 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16294263 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16294263 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16294263 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16294263 | lld:pubmed |
